Ginsenoside Rh4
CAS: 174721-08-5
Ref. 3D-OG31928
| 1mg | To inquire | ||
| 2mg | To inquire | ||
| 5mg | To inquire | ||
| 10mg | To inquire | ||
| 25mg | To inquire |
Product Information
- (3β,6α,12β,20E)-3,12-Dihydroxydammara-20(22),24-dien-6-yl β-<span class="text-smallcaps">D</span>-glucopyranoside
- Ginsenoside Rh<sub>4</sub>
- beta-D-glucopyranoside, (3beta,6alpha,12beta,20E)-3,12-dihydroxydammara-20(22),24-dien-6-yl
- β-<span class="text-smallcaps">D</span>-Glucopyranoside, (3β,6α,12β,20E)-3,12-dihydroxydammara-20(22),24-dien-6-yl
Ginsenoside Rh4 is a ginseng saponin with anti-diabetic properties. It inhibits the mitochondrial membrane potential and oxidative injury in human leukemia cells. Ginsenoside Rh4 has been shown to induce autophagy, which is a process that helps eliminate damaged or unnecessary cellular components. Ginsenoside Rh4 also reduces the release of reactive oxygen species (ROS), which may be due to its ability to inhibit Toll-like receptor 4 (TLR4) signaling pathways. Ginsenoside Rh4 has potential as a drug target for cancer treatment due to its ability to inhibit polymerase chain reaction (PCR) activity and reduce tumor size in mice models.
Chemical properties
Technical inquiry about: 3D-OG31928 Ginsenoside Rh4
If you want to request a quotation or place an order, please instead add the desired products to your cart and then request a quotation or order from the cart. It is faster, cheaper, and you will be able to benefit from the available discounts and other advantages.
